DUBLIN--(BUSINESS WIRE)--The "Paper Diagnostics - Global Market Outlook (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Global Paper Diagnostics market is accounted for $4.44 billion in 2016 and is expected to reach $9.28 billion by 2023 growing at a CAGR of 11.11%.
The rise in the prevalence of diabetes, low cost of production, growing demand for cost-efficient alternatives coupled with technological advancements, the increasing prevalence of liver disorders, the high reliability of paper diagnostics and rising geriatric population are some the key factors fueling the market growth.
Lateral flow assay kits are the largest contributors to the paper diagnostics market. The presence of diseases that require self-monitoring, for instance in diabetes mellitus, and other tests such as pregnancy test, pH test, oxygen sensing; and rising demand for cost effective devices made by technological advancements are the other major factors for paper diagnostics market growth.
The growing incidence rate of infectious diseases such as cancer, human immunodeficiency virus (HIV), and lifestyle-associated disorders such as diabetes and pre-diabetes is responsible for the increasing sales of paper diagnostics in hospitals. The market will continue to grow in the hospital segment for the upcoming years due to the bulk purchase of diagnostic kits, dipsticks, and other consumables.
- Lateral flow assay kits
- Food Quality Testing
- Environmental Monitoring
- Clinical Diagnostics
- Diagnostics Devices
- Monitoring Devices
- Home Healthcare
- Biotech-Pharma Research
- Other End Users
Key Topics Covered
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Paper Diagnostics Market, By Product
6 Global Paper Diagnostics Market, By Application
7 Global Paper Diagnostics Market, By Device Type
8 Global Paper Diagnostics Market, By End-User
9 Global Paper Diagnostics Market, By Geography
10 Key Developments
11 Company Profiling
- ACON Laboratories
- Abingdon Health
- Bio-Rad Laboratories
- Siemens Healthcare
- Sigma-Aldrich (Merck Millipore)
- SD Biosensor
- Innova Biosciences
- DCN Diagnostics
- Chembio Diagnostic Systems
- BBI Solutions
For more information about this report visit https://www.researchandmarkets.com/research/7ljr4b/global_paper?w=4